The US Food and Drug Administration (FDA) is allowing Philip Morris International (PMI) to market its Iqos 3 heated tobacco device with some reduced risk claims. The decision does not override the current ban by the International Trade Commission (ITC) on Iqos sales and imports but opens the door for the company to cite the authorisation in future marketing.
Written by TobaccoIntelligence || 15th March 2022 || News analysis | Iqos | 
North America United States
